UMIN ID: UMIN000002027
Registered date:01/06/2009
Transdermal administration of morphine to the patients with pain
Basic Information
| Recruitment status | Complete: follow-up complete |
|---|---|
| Health condition(s) or Problem(s) studied | Patients with pain |
| Date of first enrollment | 2009/06/01 |
| Target sample size | 20 |
| Countries of recruitment | Japan |
| Study type | Interventional |
| Intervention(s) | Transdermal single administration of 30mg morphine Transdermal single administration of 60mg morphine Transdermal single administration of 90mg morphine Transdermal single administration of 180mg morphine |
Outcome(s)
| Primary Outcome | Pharmacokinetics of transdermal morphine |
|---|---|
| Secondary Outcome |
Key inclusion & exclusion criteria
| Age minimum | 20years-old |
|---|---|
| Age maximum | 80years-old |
| Gender | Male and Female |
| Include criteria | |
| Exclude criteria | 1) Patients with severe respiratory disorder 2) Patients with bronchial asthma attack 3) Patients with severe liver dysfunction 4) Patients with heart failure associated with chronic lung disease 5) Patients with alcohol abuse 6) Patients susceptible with alkaloid |
Related Information
| Primary Sponsor | Department of Clinical Pharmacology and Therapeutics |
|---|---|
| Secondary Sponsor | |
| Source(s) of Monetary Support | Teika Pharmaceutical Co., Ltd. |
| Secondary ID(s) |
Contact
| public contact | |
| Name | |
| Address | Japan |
| Telephone | 053-435-2385 |
| Affiliation | Hamamatsu University School of Medicine Department of Clinical Pharmacology and Therapeutics |
| scientific contact | |
| Name | Watanabe Hiroshi |
| Address | 1-20-1 Handayama, Higashiku, Hamamatsu, Japan Japan |
| Telephone | 053-435-2385 |
| Affiliation | Hamamatsu University School of Medicine Department of Clinical Pharmacology and Therapeutics |